Revvity Signals
Guido Lerch has extensive work experience in quality and compliance, particularly in the informatics field. Guido has held various leadership roles in companies such as Revvity Signals, PerkinElmer Informatics, and PerkinElmer. At PerkinElmer, they served as the Sr. Director of Quality & Compliance, Executive Director of Quality Control & Assurance, and Executive Director of Global Services & Quality Assurance, among other positions. Prior to that, they worked at Waters as a Business Development Manager, and at NuGensis Technologies as an Application Specialist. Guido began their career at Novartis as a Lab Technician. Throughout their career, Guido's responsibilities have included project management, integration, training, and ensuring regulatory compliance.
Guido Lerch attended Gymnasium, where they pursued a degree in Mathematics and Chemistry. In 2014, they obtained a certification as an Internal Auditor from PerkinElmer Corporate Quality.
This person is not in any teams
This person is not in any offices
Revvity Signals
1 followers
Revvity Signals Software, formerly PerkinElmer Informatics, has more than three decades providing unrivaled support for scientific workflows. Our powerful informatics solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. Now under our comprehensive Signals Research Suite, our end-to-end SaaS solution integrates workflows across biology, chemistry and materials new product development to accelerate scientific innovation, and help scientists help each other. In addition, our robust solution, powered by TIBCO® Spotfire®, can revolutionize the clinical trial process. From our internationally recognized flagship ChemDraw® and E-Notebook applications, to our Signals Research Suite (Signals Notebook, Signals VitroVivo and Signals Inventa) to our exclusive TIBCO® Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.